# Safety and Efficacy of Modulated Ultrasound Renal Denervation for HTN

> **NCT06877221** · NA · RECRUITING · sponsor: **Shenzhen Pulsecare Medical Technology Co., Ltd.** · enrollment: 204 (estimated)

## Conditions studied

- Refractory Hypertension or Drug-intolerant Hypertension

## Interventions

- **PROCEDURE:** ultrasound renal denervation

## Key facts

- **NCT ID:** NCT06877221
- **Lead sponsor:** Shenzhen Pulsecare Medical Technology Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-01-25
- **Primary completion:** 2027-12
- **Final completion:** 2030-12
- **Target enrollment:** 204 (ESTIMATED)
- **Last updated:** 2025-06-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06877221

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06877221, "Safety and Efficacy of Modulated Ultrasound Renal Denervation for HTN". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06877221. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*